COMMON BRAND NAME(S): Idamycin
GENERIC NAME(S): IDARUBICIN HCL
Description: Idarubicin inhibits nucleic acid (DNA and RNA) synthesis by intercalating between DNA base pairs.
Pharmacokinetics:
Absorption: Oral admin: Variable (4-77%).
Distribution: Volume of distribution: 64 L/kg. Extensive tissue binding. Protein binding: 94-97%.
Metabolism: Hepatically to idarubicinol which is active.
Excretion: Urine and hepatic. Elimination half-life: 14-35 hr (oral); 12-27 hr (IV).